
Daniela Tomasoni
@danitomasoni_
Heart Failure Cardiologist
ASST Spedali Civili di Brescia, Italy
ID: 1659441547727732740
19-05-2023 06:11:45
71 Tweet
147 Followers
160 Following



We have a new editorial board at Heart Failure Reviews (link.springer.com/journal/10741/…). Now accepting mini-reviews, editorials, meeting minutes, and study designs. Brett Sperry, MD Peder L. Myhre MD, PhD Rishi Parikh Steve Greene Josephine Harrington, MD Senthil Selvaraj, MD, MS, MA Kelsey Flint, MD, MSCS, FACC Jan Biegus Matthew Feinstein

Global Epidemiology of Heart Failure nature.com/articles/s4156… Published now in Nature Reviews Cardiology


#HeartFailure News : What's new in heart failure? June–July 2024 onlinelibrary.wiley.com/doi/full/10.10… #EJHF European Society of Cardiology Journals Alberto Aimo


Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow-up Traditional versus Biomarker-guided HF monitoring onlinelibrary.wiley.com/doi/full/10.10… European Society of Cardiology Journals Alberto Aimo EJHF Editor-in-Chief #EJHF


What’s new in #HF June-July 24? smartphone-approach to #HF dx. #MRA efficacy + safety in pts with ⬇️ renal function. Timing to LVEF recovery 🤔? When #ICD. #SGLT2i in ATTR-CM ⬇️CV➕ HF🏥 👉 bit.ly/3xRJ7Sa EJHF Editor-in-Chief Amr Abdin Alberto Aimo Daniela Tomasoni


A new paradigm for decongestion in acute #HeartFailure. Rapid uptitration of neurohormonal blockade after HF hospitalization is associated with effective, sustainable decongestion and better outcomes. bit.ly/4bIRYU1 #JACC #STRONGHF Piotr Ponikowski Daniela Tomasoni


Form smart scales to digital biomarkers to improve remote patient monitoring in between discrete clinical encounters (link.springer.com/article/10.100…). Out now in #HREV by Marat Fudim, MD MHS and colleagues. Great overview of emerging tech! Marat Fudim, MD MHS Tor Biering-Sørensen, MD, MSc, MPH, PhD Steve Greene Andrew J Sauer MD

What's new in #HF May-June 2024? #IBD, #CKD, therapeutic inertia, #HCM doi.org/10.1002/ejhf.3… Alberto Aimo Pau Codina Verdaguer Daniela Tomasoni European Society of Cardiology Journals #EJHF


In #STRONGHF, did the safety and efficacy of GDMT titration differ according to the severity of HF risk profile? #JACCHF @jaccjournals jacc.org/doi/10.1016/j.… @adriaanvoors Jozine ter Maaten


HCM is the most common genetic heart disease, with non-obstructive HCM lacking evidence-based treatments. IMPROVE-HCM study assesses the safety and efficacy of ninerafaxstat, a novel cardiac mitotrope. Read more! (link.springer.com/article/10.100…) Daniela Tomasoni #HREV


📣 This is YOUR chance to submit your research for the #HFA Winter Research Meeting 🙌 Don’t delay and make sure you don’t miss out ✔️ #HFAYoung Novi Yanti Sari Sotiria Liori Ezman Shariff Henry Han Cornelia Margineanu Antonio Cannata' Henrike Arfsten More details ⬇️

We are back with the next HFA Journal Club—where cutting-edge research meets real talk. 📷📷 FREE for HFA members This Wednesday 23/10 | 📷 18:00 (CEST) Jozine ter Maaten Henrike Arfsten Sotiria Liori Antonio Cannata' Novi Yanti Sari European Society of Cardiology HFAPresident #HFAYoung esc365.escardio.org/event/1731

News, news, news... Don't miss it! #ESCcongress #HeartFailure EJHF Editor-in-Chief HFAPresident European Society of Cardiology Journals

What’s new in #HF Dec 2024? doi.org/10.1002/ejhf.3… #GDMT in ESC HF III Registry #HFimpEF predictors LV vol & exe capacity in #HFpEF HFpEF in repaired #Coarctation Aorta #CMR #DCMmrEF risk stratificatn #Chagas cardiomyopathy Pau Codina Verdaguer @DaniTomasoni Alberto Aimo European Society of Cardiology Journals

